<code id='9D4473E394'></code><style id='9D4473E394'></style>
    • <acronym id='9D4473E394'></acronym>
      <center id='9D4473E394'><center id='9D4473E394'><tfoot id='9D4473E394'></tfoot></center><abbr id='9D4473E394'><dir id='9D4473E394'><tfoot id='9D4473E394'></tfoot><noframes id='9D4473E394'>

    • <optgroup id='9D4473E394'><strike id='9D4473E394'><sup id='9D4473E394'></sup></strike><code id='9D4473E394'></code></optgroup>
        1. <b id='9D4473E394'><label id='9D4473E394'><select id='9D4473E394'><dt id='9D4473E394'><span id='9D4473E394'></span></dt></select></label></b><u id='9D4473E394'></u>
          <i id='9D4473E394'><strike id='9D4473E394'><tt id='9D4473E394'><pre id='9D4473E394'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:8

          Which presentations are worth catching at ASCO this weekend? What is exon-skipping? And how do you pronounce bronchiectasis?

          This week on “The Readout LOUD,” we preview some of the research that will be presented at the American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure.  

          advertisement

          To read more about Merus’ combination therapy, go here; For more on Johnson & Johnson’s mixed data, click here; For more on Nippon Shinyaku’s Duchenne drug trial failure, go here; To read more on Insmed’s bronchiectasis treatment, click here; To sign up for STAT’s ASCO newsletter, click here.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          leisure time

          New air purifier tech could be key to improving indoor air quality
          New air purifier tech could be key to improving indoor air quality

          AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

          read more
          Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO
          Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

          Wanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyourinb

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Merck to buy EyeBio, maker of eye drug, as it grows pipeline

          AdobeLONDON—MercksaidWednesdayitisbuyingophthalmology-focusedstartupEyeBioinadealworthupto$3billion,